CLINICAL RESEARCH: HEART FAILURE
Plasma B-type natriuretic peptide levels in systolic heart failure
importance of left ventricular diastolic function and right ventricular systolic function
Richard W. Troughton, MB, ChB, PhD*,
David L. Prior, MBBS, PhD ,
Jeremy J. Pereira, MBBS*,
Maureen Martin*,
Annette Fogarty, RDCS, RN*,
Annitta Morehead, RDCS, FASE*,
Timothy G. Yandle, PhD ,
A. Mark Richards, MD, PhD, DSc,
Randall C. Starling, MD, FACC ,
James B. Young, MD, FACC,
James D. Thomas, MD, FACC* and
Allan L. Klein, MD, FRCP(C), FACC, FASE*,*
* Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA
St. Vincent's Department of Medicine, University of Melbourne, Melbourne, Australia
Christchurch Cardioendocrine Research Group, Christchurch, New Zealand
Manuscript received May 13, 2003;
revised manuscript received August 4, 2003,
accepted August 25, 2003.
* Reprint requests and correspondence: Dr. Allan L. Klein, Director of Cardiovascular Imaging Research, Department of Cardiovascular Medicine, Professor of Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F-15, Cleveland, Ohio 44195, USA.
kleina{at}ccf.org
OBJECTIVES: This study was designed to characterize the importance of echocardiographic indexes, including newer indexes of diastolic function, as determinants of plasma B-type natriuretic peptide (BNP) levels in patients with systolic heart failure (SHF).
BACKGROUND: Plasma BNP levels have utility for diagnosing and managing heart failure. However, there is significant heterogeneity in BNP levels that is not explained by left ventricular size and function alone.
METHODS: In 106 patients with symptomatic SHF (left ventricular ejection fraction [LVEF] <0.35), we measured plasma BNP levels and performed comprehensive echocardiography with assessment of left ventricular diastolic function, including color M-mode (CMM) and tissue Doppler imaging (TDI), and of right ventricular (RV) function.
RESULTS: Median plasma BNP levels were elevated and increased with greater severity of diastolic dysfunction. We found significant correlations (p < 0.001 for all) between BNP and indexes of myocardial relaxation (early diastolic velocity: r = –0.26), compliance (deceleration time: r = –0.55), and filling pressure (early transmitral to early annular diastolic velocity ratio: r = 0.51; early transmitral flow to the velocity of early left ventricular flow propagation ratio: r = 0.41). In multivariate analysis, overall diastolic stage, LVEF, RV systolic dysfunction, mitral regurgitation (MR) severity, age and creatinine clearance were independent predictors of BNP levels (model fit r = 0.8, p < 0.001).
CONCLUSIONS: Plasma BNP levels are significantly related to newer diastolic indexes measured from TDI and CMM in SHF. Heterogeneity of BNP levels in patients with SHF reflects the severity of diastolic abnormality, RV dysfunction, and MR in addition to LVEF, age, and renal function. These findings may explain the powerful relationship of BNP to symptoms and prognosis in SHF.
|
Abbreviations and Acronyms
| | AR | = atrial reversal | | BNP | = B-type natriuretic peptide | | CMM | = color M-mode | | DT | = deceleration time | | IQR | = interquartile range | | LVEF | = left ventricular ejection fraction | | MR | = mitral regurgitation | | NYHA | = New York Heart Association | | PV | = pulmonary vein | | RV | = right ventricle/ventricular | | SHF | = systolic heart failure | | TDI | = tissue Doppler imaging | | TR | = tricuspid regurgitation | | Vp | = velocity of early left ventricular flow propagation |
|
This article has been cited by other articles:
|
|
|
|
 
K. B. Shah, W. J. Kop, R. H. Christenson, D. B. Diercks, D. Kuo, S. Henderson, K. Hanson, S.-Y. Li, and C. R. deFilippi
Natriuretic peptides and echocardiography in acute dyspnoea: implication of elevated levels with normal systolic function
Eur J Heart Fail,
July 1, 2009;
11(7):
659 - 667.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Sallach, W.H. W. Tang, A. G. Borowski, W. Tong, T. Porter, M. G. Martin, S. E. Jasper, K. Shrestha, R. W. Troughton, and A. L. Klein
Right atrial volume index in chronic systolic heart failure and prognosis.
J. Am. Coll. Cardiol. Img.,
May 1, 2009;
2(5):
527 - 534.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. Troughton and A. M. Richards
B-type natriuretic peptides and echocardiographic measures of cardiac structure and function.
J. Am. Coll. Cardiol. Img.,
February 1, 2009;
2(2):
216 - 225.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al.
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
December 2, 2008;
52(23):
e143 - e263.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al.
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation,
December 2, 2008;
118(23):
e714 - e833.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Tagore, L. H. Ling, H. Yang, H.-Y. Daw, Y.-H. Chan, and S. K. Sethi
Natriuretic Peptides in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol.,
November 1, 2008;
3(6):
1644 - 1651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. L. Dini, P. Fontanive, E. Panicucci, D. Andreini, P. Chella, and S. M. De Tommasi
Prognostic significance of tricuspid annular motion and plasma NT-proBNP in patients with heart failure and moderate-to-severe functional mitral regurgitation
Eur J Heart Fail,
June 1, 2008;
10(6):
573 - 580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. A. Whalley, S. P. Wright, A. Pearl, G. D. Gamble, H. J. Walsh, M. Richards, and R. N. Doughty
Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community
Eur. Heart J.,
February 2, 2008;
29(4):
509 - 516.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Mueller
B-Type Natriuretic Peptides and the General Practitioner
J. Am. Coll. Cardiol.,
October 23, 2007;
50(17):
1702 - 1703.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Konduracka, A. Gackowski, P. Rostoff, D. Galicka-Latala, W. Frasik, and W. Piwowarska
Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy
Eur. Heart J.,
October 2, 2007;
28(20):
2465 - 2471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. G. Olsson, K. Swedberg, J. G.F. Cleland, P. A. Spark, M. Komajda, M. Metra, C. Torp-Pedersen, W. J. Remme, A. Scherhag, P. Poole-Wilson, et al.
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a {beta}-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial
Eur J Heart Fail,
August 1, 2007;
9(8):
795 - 801.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.H. Wilson Tang, G. S. Francis, D. A. Morrow, L. K. Newby, C. P. Cannon, R. L. Jesse, A. B. Storrow, R. H. Christenson, COMMITTEE MEMBERS, R. H. Christenson, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
Circulation,
July 31, 2007;
116(5):
e99 - e109.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.H. W. Tang, W. Tong, R. W. Troughton, M. G. Martin, K. Shrestha, A. Borowski, S. Jasper, S. L. Hazen, and A. L. Klein
Prognostic Value and Echocardiographic Determinants of Plasma Myeloperoxidase Levels in Chronic Heart Failure
J. Am. Coll. Cardiol.,
June 19, 2007;
49(24):
2364 - 2370.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. H. Rutten, M.-J. M. Cramer, N. P.A. Zuithoff, J.-W. J. Lammers, W. Verweij, D. E. Grobbee, and A. W. Hoes
Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease
Eur J Heart Fail,
June 1, 2007;
9(6-7):
651 - 659.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-M. Yu, J. E. Sanderson, T. H. Marwick, and J. K. Oh
Tissue Doppler Imaging: A New Prognosticator for Cardiovascular Diseases
J. Am. Coll. Cardiol.,
May 15, 2007;
49(19):
1903 - 1914.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Th. Kremastinos, D. P. Tsiapras, A. G. Kostopoulou, E. S. Hamodraka, A. S. Chaidaroglou, and E. D. Kapsali
NT-proBNP levels and diastolic dysfunction in {beta}-Thalassaemia major patients
Eur J Heart Fail,
May 1, 2007;
9(5):
531 - 536.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. B. Scardovi, C. Coletta, N. Aspromonte, S. Perna, M. Greggi, P. D'Errigo, A. Sestili, and V. Ceci
Brain natriuretic peptide plasma level is a reliable indicator of advanced diastolic dysfunction in patients with chronic heart failure
Eur J Echocardiogr,
January 1, 2007;
8(1):
30 - 36.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Cortes, M. Portoles, A. Salvador, V. Bertomeu, F. G. de Burgos, L. Martinez-Dolz, E. R. Lleti, V. Climent, A. Jordan, R. Paya, et al.
Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients
Eur J Heart Fail,
October 1, 2006;
8(6):
621 - 627.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Lainchbury, R. W. Troughton, C. M. Frampton, T. G. Yandle, A. Hamid, M. G. Nicholls, and A. M. Richards
NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial
Eur J Heart Fail,
August 1, 2006;
8(5):
532 - 538.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B Norager, M Husic, J E Moller, A Bo Hansen, P A Pellikka, and K Egstrup
Changes in the Doppler myocardial performance index during dobutamine echocardiography: association with neurohormonal activation and prognosis after acute myocardial infarction
Heart,
August 1, 2006;
92(8):
1071 - 1076.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Moller, P. A. Pellikka, G. S. Hillis, and J. K. Oh
Prognostic Importance of Diastolic Function and Filling Pressure in Patients With Acute Myocardial Infarction
Circulation,
August 1, 2006;
114(5):
438 - 444.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. A. Chen, M. J. Wood, D. G. Krauser, A. L. Baggish, R. Tung, S. Anwaruddin, M. H. Picard, and J. L. Januzzi
NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy
Eur. Heart J.,
April 1, 2006;
27(7):
839 - 845.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Iwanaga, I. Nishi, S. Furuichi, T. Noguchi, K. Sase, Y. Kihara, Y. Goto, and H. Nonogi
B-Type Natriuretic Peptide Strongly Reflects Diastolic Wall Stress in Patients With Chronic Heart Failure: Comparison Between Systolic and Diastolic Heart Failure
J. Am. Coll. Cardiol.,
February 21, 2006;
47(4):
742 - 748.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ichihara, A. Noda, K. Nagata, K. Obata, J. Xu, G. Ichihara, S. Oikawa, S. Kawanishi, Y. Yamada, and M. Yokota
Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure
Cardiovasc Res,
February 15, 2006;
69(3):
726 - 735.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Maisel
The Coming of Age of Natriuretic Peptides: The Emperor Does Have Clothes!
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
61 - 64.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Valle, E. Bagolin, C. Canali, P. Giovinazzo, S. Barro, N. Aspromonte, E. Carbonieri, and L. Milani
The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients
Eur J Echocardiogr,
January 1, 2006;
7(1):
40 - 44.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. H Rutten, K. G M Moons, M.-J. M Cramer, D. E Grobbee, N. P A Zuithoff, J.-W. J Lammers, and A. W Hoes
Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study
BMJ,
December 10, 2005;
331(7529):
1379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Tschope, M. Kasner, D. Westermann, R. Gaub, W. C. Poller, and H.-P. Schultheiss
The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements
Eur. Heart J.,
November 1, 2005;
26(21):
2277 - 2284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Tretjak, F. Verovnik, D. Benko, and M. Kozelj
Tissue Doppler velocities of mitral annulus and NT-proBNP in patients with heart failure
Eur J Heart Fail,
June 1, 2005;
7(4):
520 - 524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Kistorp, I. Raymond, F. Pedersen, F. Gustafsson, J. Faber, and P. Hildebrandt
N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults
JAMA,
April 6, 2005;
293(13):
1609 - 1616.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Nishikimi, H. Matsuoka, W.H. W. Tang, R. C. Starling, J. B. Young, G. S. Francis, J. P. Girod, M. J. Lee, and F. Van Lente
Plasma Brain Natriuretic Peptide Levels Indicate the Distance From Decompensated Heart Failure * Response
Circulation,
June 29, 2004;
109(25):
e329 - e330.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Sharp and J. Mayet
Review: The utility of BNP in clinical practice
Journal of Renin-Angiotensin-Aldosterone System,
June 1, 2004;
5(2):
53 - 58.
[Abstract]
[PDF]
|
|
|
|
